Equine Biotech Private Limited
About Equine Biotech Private Limited
Data last updated:
Equine Biotech Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 01 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2015PTC080077. Its GSTIN is 29AADCE9425B2ZP (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neela Utpal Tatu and Utpal Shashikant Tatu.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Villa 95 Prestige Oasis Addevishwanathpura Rajankunte Doddabelapur Road, Bangalore, Karnataka, India – 560064.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.61 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹42.45 Lakh (net margin 16.3%) and EBITDA of ₹63.39 Lakh (EBITDA margin 24.3%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 42% over five years.
As per MCA filings, the company has open charges of ₹5.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVilla 95 Prestige Oasis Addevishwanathpura Rajankunte Doddabelapur Road, Bangalore, Karnataka, India – 560064
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Equine Biotech Private Limited
The main business activity of Equine Biotech is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Equine Biotech Private Limited FY 2023 filings available
Equine Biotech Private Limited reported revenue of ₹2.61 Cr (down 10% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Equine Biotech Private Limited
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 42%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Equine Biotech Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹2.61 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹63.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹42.45 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Equine Biotech Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 16.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Equine Biotech are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Equine Biotech Private Limited
Equine Biotech Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Golden Trees Biotech Private Limited | ₹2.65 Cr (FY 2015) | •••• | •••• | -37.0% | •••• | Coimbatore, Tamil Nadu, India |
| Icri Life Sciences Private Limited | ₹2.64 Cr (FY 2023) | •••• | •••• | 213.0% | •••• | New Delhi, Delhi, India |
| Innov4sight Health and Biomedical Systems Private Limited | ₹2.63 Cr (FY 2018) | •••• | •••• | 92.0% | •••• | Bangalore, Karnataka, India |
| Adonis Biotech Private Limited | ₹2.62 Cr (FY 2024) | •••• | •••• | 102.0% | •••• | Jaipur, Rajasthan, India |
| Biohouse Solutions Private Limited | ₹2.61 Cr (FY 2023) | •••• | •••• | -36.0% | •••• | New Delhi, Delhi, India |
| Equine Biotech Private Limited this company | ₹2.61 Cr (FY 2023) | •••• | •••• | -10.0% | •••• | Bangalore, Karnataka, India |
| Dr J R Raju Ayurvedic Integrated Medical and Research Institute Private Limited | ₹2.6 Cr (FY 2022) | •••• | •••• | 10.0% | •••• | Hyderabad, Telangana, India |
| Galoretx Pharmaceuticals Private Limited | ₹2.52 Cr (FY 2024) | •••• | •••• | 41.0% | •••• | Udupi, Karnataka, India |
| Aib Life Science Private Limited | ₹2.47 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Bhagalpur, Bihar, India |
| Reagent Ivd Resources Private Limited | ₹2.46 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Jaipur, Rajasthan, India |
| Chembond Polymers and Materials Limited | ₹2.38 Cr (FY 2023) | •••• | •••• | -6.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Equine Biotech by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Equine Biotech Private Limited
Equine Biotech Private Limited is audited by B N Subramanya & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B N Subramanya & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Equine Biotech Private Limited
Equine Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neela Utpal Tatu | Director | 01 May 2015 | 11 Years 5 Months | Current |
| Utpal Shashikant Tatu | Director | 01 May 2015 | 11 Years 5 Months | Current |
Ownership and Shareholding of Equine Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Equine Biotech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Dec 2024 | Hdfc Bank Limited | ₹5.5 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Equine Biotech Private Limited
Employment history and EPFO contributions of people linked to Equine Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Equine Biotech Private Limited
Equine Biotech Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Neela Utpal Tatu was appointed as Director on 01 May 2015.
Credit Ratings, Litigation & Regulatory Alerts for Equine Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Equine Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Equine Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Equine Biotech Private Limited
Equine Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCE9425B2ZP | Karnataka | Active | 02 Sep 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Equine Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Equine Biotech Private Limited
Equine Biotech is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 01 May 2015 (11+ years old) and is registered under CIN U74900KA2015PTC080077.
Equine Biotech reported revenue of ₹2.61 Cr for FY 2023 (down 10% YoY).
Equine Biotech has 2 current directors:
- Neela Utpal Tatu - Director
- Utpal Shashikant Tatu - Director
Equine Biotech reported a net profit of ₹42.45 Lakh (net margin 16.3%) and EBITDA of ₹63.39 Lakh (EBITDA margin 24.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Equine Biotech is 20% over three years and 42% over five years. In the latest year (FY 2023) revenue fell 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Equine Biotech is 29AADCE9425B2ZP, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Equine Biotech is U74900KA2015PTC080077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Equine Biotech was incorporated on 01 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Equine Biotech by revenue are Golden Trees Biotech Private Limited, Icri Life Sciences Private Limited, Innov4sight Health and Biomedical Systems Private Limited, Adonis Biotech Private Limited, Biohouse Solutions Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Neela Utpal Tatu was appointed as Director on 01 May 2015. Utpal Shashikant Tatu was appointed as Director on 01 May 2015.
Yes, Equine Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).